Modest growth in revenue despite lack of profitability may be driving share price increase. Signs of growth acceleration and insider buying warrant closer attention.
Gainers: •$ロケット ファーマシューティカルズ(RCKT.US)$+10.5% (Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy) •$カナダ・グース(GOOS.US)$+9.4% (the company reported an unexpected profit as well as better-than-expected revenue) •$シガ テクノロジーズ(SIGA.US)$+6.4% (FDA approves Intravenous (IV) Formulation of TPOXX (tecovirimat) for t...
エイチ シー アイ グループに関するコメント
• $ロケット ファーマシューティカルズ(RCKT.US)$ +10.5% (Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy)
• $カナダ・グース(GOOS.US)$ +9.4% (the company reported an unexpected profit as well as better-than-expected revenue)
• $シガ テクノロジーズ(SIGA.US)$ +6.4% (FDA approves Intravenous (IV) Formulation of TPOXX (tecovirimat) for t...
まだコメントはありません